Rxi Pharmaceuticals (RXII)
0.33 unch (unch) 11/16/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Nov 16th, 2018
Results
download Want to compare other data? Select FieldsSymbol | RXII | SXTC | UPC | ||
Company | Rxi Pharmaceuticals | China Sxt Pharmaceuticals Inc | Universe Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.33 | 2.35 | 5.41 | ||
High | 0.33 | 2.41 | 5.41 | ||
Low | 0.32 | 2.02 | 4.31 | ||
Last | 0.33 | 2.20 | 4.38 | ||
Change | unch | -0.23 | -1.57 | ||
% Change | unch | -9.47% | -26.39% | ||
Volume | 461,100 | 484,500 | 343,800 | ||
20-Day Average Volume | 1,725,540 | 10,707,210 | 758,680 | ||
Previous Close | 0.33 | 2.43 | 5.95 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.41 | 2.19 | 3.66 | ||
20-Day Raw Stochastic | 10.53% | 54.67% | 42.31% | ||
20-Day Relative Strength | 30.13% | 47.67% | 42.65% | ||
Weighted Alpha | -94.27 | -78.55 | -91.82 | ||
Today's Opinion | N/A | 88% Sell | 80% Sell | ||
Previous Opinion | N/A | 88% Sell | 64% Sell | ||
Last Month's Opinion | N/A | 88% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -23.26% since 11/09/18 | +5.77% since 04/22/25 | +21.33% since 04/22/25 | ||
Low | 0.31 on 11/15/18 | 1.43 on 04/24/25 | 3.61 on 04/24/25 | ||
High | 0.41 on 11/12/18 | 2.98 on 04/25/25 | 6.93 on 04/28/25 | ||
1-Month | |||||
%Chg | -26.67% since 10/16/18 | -19.96% since 03/28/25 | -10.43% since 03/28/25 | ||
Low | 0.31 on 11/15/18 | 0.97 on 04/16/25 | 2.51 on 04/03/25 | ||
High | 0.50 on 11/08/18 | 3.22 on 04/22/25 | 6.93 on 04/28/25 | ||
3-Month | |||||
%Chg | -78.29% since 08/16/18 | -33.09% since 01/29/25 | -75.67% since 01/29/25 | ||
Low | 0.31 on 11/15/18 | 0.97 on 04/16/25 | 2.51 on 04/03/25 | ||
High | 2.19 on 09/27/18 | 7.84 on 02/24/25 | 18.00 on 01/30/25 | ||
6-Month | |||||
%Chg | -86.08% since 05/16/18 | -55.17% since 10/29/24 | -97.66% since 10/29/24 | ||
Low | 0.31 on 11/15/18 | 0.97 on 04/16/25 | 2.51 on 04/03/25 | ||
High | 2.84 on 05/18/18 | 7.84 on 02/24/25 | 197.20 on 12/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,445 | 1,757 | 255 | ||
Shares Outstanding, K | 4,380 | 723 | 43 | ||
Annual Sales | 20,000 | 1,930,000 | 32,310,000 | ||
Annual Net Income | -12,450,000 | -3,100,000 | -6,160,000 | ||
Last Quarter Sales | 60,000 | N/A | N/A | ||
Last Quarter Net Income | -1,900,000 | N/A | N/A | ||
60-Month Beta | 2.07 | 1.03 | 1.56 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A | N/A | ||
Latest Earnings Date | 11/14/18 | 11/12/24 | 02/04/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |